Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 8.4 1.08% 0.09
PRTK closed up 1.08 percent on Wednesday, April 14, 2021, on 89 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical PRTK trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 1.08%
Older End-of-Day Signals for PRTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Upper Bollinger Band Resistance about 6 hours ago
Possible Pocket Pivot about 6 hours ago
Up 3% about 9 hours ago
60 Minute Opening Range Breakout about 9 hours ago
Rose Above Previous Day's High about 9 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Paratek Pharmaceuticals, Inc. Description

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Organ Systems Antibiotic Infection Multiple Sclerosis SMS Bacterial Infections Antibiotics Acne Hepatotoxins Pneumonia Urinary Tract Infection Rosacea Urinary Tract Infections Skin And Skin Structure Infection Skin And Skin Structure Infections Bacterial Pneumonia Community Acquired Bacterial Pneumonia Omadacycline Tetracycline

Is PRTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.75
52 Week Low 3.81
Average Volume 518,346
200-Day Moving Average 6.05
50-Day Moving Average 7.53
20-Day Moving Average 7.46
10-Day Moving Average 7.50
Average True Range 0.44
ADX 22.74
+DI 31.92
-DI 14.66
Chandelier Exit (Long, 3 ATRs ) 7.32
Chandelier Exit (Short, 3 ATRs ) 7.86
Upper Bollinger Band 8.48
Lower Bollinger Band 6.43
Percent B (%b) 0.96
BandWidth 27.42
MACD Line 0.15
MACD Signal Line 0.01
MACD Histogram 0.1466
Fundamentals Value
Market Cap 383.39 Million
Num Shares 45.6 Million
EPS -3.85
Price-to-Earnings (P/E) Ratio -2.18
Price-to-Sales 6.68
Price-to-Book 0.00
PEG Ratio -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.18
Resistance 3 (R3) 9.18 8.91 9.05
Resistance 2 (R2) 8.91 8.71 8.91 9.01
Resistance 1 (R1) 8.65 8.59 8.78 8.66 8.97
Pivot Point 8.39 8.39 8.45 8.39 8.39
Support 1 (S1) 8.13 8.19 8.26 8.14 7.83
Support 2 (S2) 7.86 8.06 7.87 7.79
Support 3 (S3) 7.61 7.86 7.75
Support 4 (S4) 7.62